Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
05/2007
05/08/2007US7214673 For therapy of psychosis and bipolar disorder
05/03/2007WO2007049582A1 Thiopeptide compound
05/03/2007WO2007048732A1 Use of 5-aminopyrazoles for controlling phytopathogenic harmful fungi, novel 5-aminopyrazoles, process for their preparation and composition comprising them
05/03/2007WO2006122011A3 Thiazole compounds and methods of use
05/03/2007US20070099940 Pth agonists
05/02/2007EP1778642A1 5-ht7 receptor antagonosts
05/02/2007EP1778641A1 5-ht7 receptor antagonists
05/02/2007EP1546134B1 Piperazine substituted aryl benzodiazepines
05/02/2007EP1033137B1 Diagnostic reagent for complications associated with diabetes or renal failure
05/01/2007US7211574 Central nervous system disorders; eating disorders; antidiabetic agents
04/2007
04/26/2007WO2007045588A1 Isothiazolopyridin-3-ylenamines for combating animal pests
04/26/2007US20070093526 4-Amino-piperidine derivatives as monoamine uptake inhibitors
04/26/2007US20070093430 Interferons; polyoxyethylene glycol
04/25/2007EP1776368A1 Inhibitors of hcv replication
04/25/2007CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer
04/25/2007CN1951917A Pyridinone derivatives for treatment of atherosclerosis
04/24/2007CA2171934C Endothelin receptor antagonists
04/24/2007CA2166811C Tricyclic inhibitors of the gpiibiiia receptor
04/19/2007WO2007042325A1 Antibacterial active 5-chinolin derivative
04/19/2007WO2006101217A3 Luminous compound containing lanthanide ion
04/19/2007US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects;
04/19/2007US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
04/19/2007CA2625687A1 Antibacterial active 5-chinolin derivative
04/18/2007EP1773846A1 Indoleamine 2,3-dioxygenase (ido) inhibitors
04/18/2007EP1773844A1 Compounds having affinity for the dopamine d3 receptor and uses thereof in medicine
04/18/2007EP1773830A1 Fused pyrimidones useful in the treatment and the prevention of cancer
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773807A2 Kinase inhibitors
04/18/2007EP1773348A2 Tetrapeptide analogs
04/18/2007EP1773331A1 Imidazole and thiazole derivatives as antiviral agents
04/18/2007CN1950381A Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity
04/17/2007US7205410 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting
04/17/2007US7205408 Therapy for bacteria infections in mammals
04/17/2007US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
04/17/2007US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205300 Aryl fused azapolycyclic compounds
04/17/2007CA2350073C Ccr5 modulators
04/12/2007WO2007041366A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/12/2007WO2007041365A2 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
04/12/2007WO2007039616A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides
04/12/2007WO2007039285A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2
04/12/2007WO2006114401A3 Novel cyclic amines
04/12/2007CA2624493A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides
04/12/2007CA2624468A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2
04/12/2007CA2623686A1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
04/12/2007CA2623045A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/11/2007EP1772493A1 Azo dye
04/11/2007EP1771450A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/11/2007EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
04/11/2007EP1015439B1 Prenyl transferase inhibitors
04/11/2007CN1946718A Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
04/11/2007CN1309385C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
04/10/2007CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof
04/05/2007US20070078130 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases
04/04/2007EP1219609B1 Aromatic nitrogenous six-membered ring compounds
04/04/2007CN1939915A 喹啉衍生物 Quinoline derivatives
04/04/2007CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
04/04/2007CN1308316C Alpha-phenyl-beta-ketosulfone
04/03/2007US7199128 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
04/03/2007US7199125 Spiro-cyclic compounds useful as anti-inflammatory agents
04/03/2007US7199119 Antiinflammation agents
03/2007
03/29/2007WO2007034510A1 Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof
03/29/2007WO2007034278A2 Fused imidazole derivatives as c3a receptor antagonists
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007US20070073060 Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's disease
03/29/2007US20070072865 Bicyclic piperazine compound and use thereof
03/29/2007US20070072792 Macrocyclic lactams and pharmaceutical use thereof
03/29/2007DE10116303B4 Vefahren zur Herstellung N-überbrückter Heterobicyclen Vefahren for preparing N-bridged heterobicycles
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/27/2007US7196200 5-oxo-5,8-dihydro[2,3-d]pyrimidinopyridine-6-carboxylic acids or 7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acids; fish or mammals; bacterial protein biosynthesis inhibitors
03/27/2007US7196194 for color photography
03/27/2007US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection
03/27/2007US7196083 Antiproliferative or anticarcinogenic agents comprising reaction products of ninhydrin or benzo(f)ninhydrin with 1,5-diaminotetrazole; enzyme inhibitors
03/27/2007US7195885 Hepatitis C virus assays
03/22/2007WO2006098961A3 Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity
03/22/2007US20070066823 CCR9 inhibitors and methods of use thereof
03/22/2007US20070066587 Substituted azetidine compounds, their preparation and use as medicaments
03/22/2007US20070066577 Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
03/22/2007CA2617394A1 2-aniline-4-aryl substituted thiazole derivatives
03/21/2007EP1763524A1 Indole derivatives and use thereof as kinase inhibitors
03/21/2007EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
03/21/2007CN1934116A Tricyclic benzopyran compound as anti-arrhythmic agents
03/21/2007CN1934100A Substituted quinazoline or pyridopyrimidine derivative
03/21/2007CN1934094A Diaryl-substituted five-membered heterocycle derivative
03/20/2007US7193237 Organic semiconductor material and organic electronic device
03/20/2007US7192968 Ethylenediamine derivatives
03/20/2007US7192948 Bicyclic heterocycles as HIV integrase inhibitors
03/20/2007US7192763 Streptomyces anulatus microorganism and a process for producing the substance GM-95
03/20/2007CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins
03/15/2007WO2007030487A2 Pyrrolo-thiazines and processes for the preparation and use thereof
03/15/2007WO2007028654A1 Pyridine derivatives and their use in the treatment of psychotic disorders
03/15/2007US20070060629 Large conductance calcium-activated k channel opener
03/15/2007US20070060568 5HT2c receptor modulators
03/15/2007CA2621717A1 Pyrrolo-thiazines and processes for the preparation and use thereof
03/15/2007CA2621564A1 Pyridine derivatives and their use in the treatment of psychotic disorders
03/14/2007EP1761532A1 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/14/2007EP1761497A2 Azadecalin glucocorticoid receptor modulators
03/14/2007CN1930170A Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
03/13/2007US7189851 Condensed heterocyclic compounds as calcitonin agonists
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 152